Your browser doesn't support javascript.
Montrer: 20 | 50 | 100
Résultats 1 - 5 de 5
Filtre
1.
Viruses ; 13(7)2021 07 15.
Article Dans Anglais | MEDLINE | ID: covidwho-1448933

Résumé

Virus-induced infections of the central nervous system (CNS) are among the most serious problems in public health and can be associated with high rates of morbidity and mortality, mainly in low- and middle-income countries, where these manifestations have been neglected. Typically, herpes simplex virus 1 and 2, varicella-zoster, and enterovirus are responsible for a high number of cases in immunocompetent hosts, whereas other herpesviruses (for example, cytomegalovirus) are the most common in immunocompromised individuals. Arboviruses have also been associated with outbreaks with a high burden of neurological disorders, such as the Zika virus epidemic in Brazil. There is a current lack of understanding in Brazil about the most common viruses involved in CNS infections. In this review, we briefly summarize the most recent studies and findings associated with the CNS, in addition to epidemiological data that provide extensive information on the circulation and diversity of the most common neuro-invasive viruses in Brazil. We also highlight important aspects of the prion-associated diseases. This review provides readers with better knowledge of virus-associated CNS infections. A deeper understanding of these infections will support the improvement of the current surveillance strategies to allow the timely monitoring of the emergence/re-emergence of neurotropic viruses.


Sujets)
Maladies du système nerveux central/virologie , Infections du système nerveux central/épidémiologie , Maladies à prions/épidémiologie , Alphavirus/pathogénicité , Brésil/épidémiologie , Système nerveux central/virologie , Maladies du système nerveux central/métabolisme , Maladies du système nerveux central/physiopathologie , Infections du système nerveux central/virologie , Maladies virales du système nerveux central/physiopathologie , Maladies virales du système nerveux central/virologie , Enterovirus/pathogénicité , Flavivirus/pathogénicité , Herpesviridae/pathogénicité , Humains , Maladies du système nerveux/épidémiologie , Maladies du système nerveux/virologie , Maladies à prions/physiopathologie , Prions/métabolisme , Prions/pathogénicité , Simplexvirus/pathogénicité , Maladies virales/virologie , Virus/pathogénicité , Virus Zika/pathogénicité
2.
Cells ; 10(4)2021 03 28.
Article Dans Anglais | MEDLINE | ID: covidwho-1154291

Résumé

Parkinson's disease (PD) is the most common neurodegenerative movement disorder, characterized by progressive loss of dopaminergic neurons in the substantia nigra, intraneuronal deposition of misfolded proteins known as Lewy bodies, and chronic neuroinflammation. PD can arise from monogenic mutations, but in most cases, the etiology is unclear. Viral infection is gaining increasing attentions as a trigger of PD. In this study, we investigated whether the PD-causative 620 aspartate (D) to asparagine (N) mutation in the vacuolar protein sorting 35 ortholog (Vps35) precipitated herpes simplex virus (HSV) infection. We observed that ectopic expression of Vps35 significantly reduced the proliferation and release of HSV-1 virions; the D620N mutation rendered Vps35 a partial loss of such inhibitory effects. Tetherin is a host cell protein capable of restricting the spread of encapsulated viruses including HSV-1 and SARS-Cov-2, both of which are implicated in the development of parkinsonism. Compared with cells overexpressing wildtype Vps35, cells expressing mutant Vps35 with D620N had less Tetherin on cell surfaces. Real-time and static cell imaging revealed that Tetherin recycled through Vps35-positive endosomes. Expression of Vps35 with D620N reduced endosomal dynamics and frequency of motile Tetherin-containing vesicles, a sign of defective production of recycling carriers. Our study suggests that the D620N mutation in Vps35 hinders Tetherin trafficking to cell surfaces and facilitates virus spread.


Sujets)
Antigène stromal-2 de la moëlle osseuse/métabolisme , Maladie de Parkinson/métabolisme , Maladie de Parkinson/virologie , Simplexvirus/métabolisme , Protéines du transport vésiculaire/métabolisme , COVID-19/virologie , Lignée cellulaire tumorale , Endosomes/métabolisme , Humains , Mutation , Maladie de Parkinson/génétique , Transport des protéines/génétique , SARS-CoV-2/croissance et développement , SARS-CoV-2/métabolisme , SARS-CoV-2/pathogénicité , Simplexvirus/pathogénicité , Transfection , Protéines du transport vésiculaire/génétique , Réplication virale/génétique
4.
Molecules ; 25(21)2020 Oct 22.
Article Dans Anglais | MEDLINE | ID: covidwho-983187

Résumé

Viral infections and associated diseases are responsible for a substantial number of mortality and public health problems around the world. Each year, infectious diseases kill 3.5 million people worldwide. The current pandemic caused by COVID-19 has become the greatest health hazard to people in their lifetime. There are many antiviral drugs and vaccines available against viruses, but they have many disadvantages, too. There are numerous side effects for conventional drugs, and active mutation also creates drug resistance against various viruses. This has led scientists to search herbs as a source for the discovery of more efficient new antivirals. According to the World Health Organization (WHO), 65% of the world population is in the practice of using plants and herbs as part of treatment modality. Additionally, plants have an advantage in drug discovery based on their long-term use by humans, and a reduced toxicity and abundance of bioactive compounds can be expected as a result. In this review, we have highlighted the important viruses, their drug targets, and their replication cycle. We provide in-depth and insightful information about the most favorable plant extracts and their derived phytochemicals against viral targets. Our major conclusion is that plant extracts and their isolated pure compounds are essential sources for the current viral infections and useful for future challenges.


Sujets)
Antiviraux/usage thérapeutique , Infections à coronavirus/traitement médicamenteux , Infections à VIH/traitement médicamenteux , Hépatite C chronique/traitement médicamenteux , Herpès/traitement médicamenteux , Grippe humaine/traitement médicamenteux , Composés phytochimiques/usage thérapeutique , Pneumopathie virale/traitement médicamenteux , Antiviraux/composition chimique , Antiviraux/classification , Antiviraux/isolement et purification , Betacoronavirus/effets des médicaments et des substances chimiques , Betacoronavirus/pathogénicité , Betacoronavirus/physiologie , COVID-19 , Infections à coronavirus/anatomopathologie , Infections à coronavirus/virologie , Découverte de médicament , VIH (Virus de l'Immunodéficience Humaine)/effets des médicaments et des substances chimiques , VIH (Virus de l'Immunodéficience Humaine)/pathogénicité , VIH (Virus de l'Immunodéficience Humaine)/physiologie , Infections à VIH/anatomopathologie , Infections à VIH/virologie , Hepacivirus/effets des médicaments et des substances chimiques , Hepacivirus/pathogénicité , Hepacivirus/physiologie , Hépatite C chronique/anatomopathologie , Hépatite C chronique/virologie , Herpès/anatomopathologie , Herpès/virologie , Humains , Grippe humaine/anatomopathologie , Grippe humaine/virologie , Orthomyxoviridae/effets des médicaments et des substances chimiques , Orthomyxoviridae/pathogénicité , Orthomyxoviridae/physiologie , Pandémies , Composés phytochimiques/composition chimique , Composés phytochimiques/classification , Composés phytochimiques/isolement et purification , Plantes médicinales , Pneumopathie virale/anatomopathologie , Pneumopathie virale/virologie , SARS-CoV-2 , Simplexvirus/effets des médicaments et des substances chimiques , Simplexvirus/pathogénicité , Simplexvirus/physiologie , Pénétration virale/effets des médicaments et des substances chimiques , Réplication virale/effets des médicaments et des substances chimiques
5.
J Cataract Refract Surg ; 46(12): e61-e63, 2020 12.
Article Dans Anglais | MEDLINE | ID: covidwho-910345

Résumé

This case report describes a negative result for antigen testing for the SARS-CoV-2 virus in an aqueous sample taken during the management of suspected herpes simplex keratitis from a patient with confirmed SARS-CoV-2 based on antigen testing of high nasal swab. The implications of no viral load detectable in the aqueous sample are discussed in context of routine phacoemulsification surgery during the SARS-CoV-2 pandemic.


Sujets)
Humeur aqueuse/virologie , Détection de l'acide nucléique du virus de la COVID-19 , COVID-19/diagnostic , Stroma de la cornée/virologie , Kératite herpétique/diagnostic , SARS-CoV-2/isolement et purification , Antiviraux/usage thérapeutique , COVID-19/génétique , COVID-19/virologie , Ganciclovir/usage thérapeutique , Humains , Kératite herpétique/traitement médicamenteux , Kératite herpétique/virologie , Mâle , Adulte d'âge moyen , Récidive , RT-PCR , SARS-CoV-2/génétique , Simplexvirus/pathogénicité , Acuité visuelle/physiologie
SÉLECTION CITATIONS
Détails de la recherche